Insufficient scRNA-seq data for expression of CRYGS at single-cell level.
Insufficient scRNA-seq data for expression of CRYGS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 230.73 | 2619 / 2642 | 100% | 8.03 | 705 / 705 |
uterus | 99% | 206.82 | 169 / 170 | 97% | 5.14 | 447 / 459 |
pancreas | 100% | 132.12 | 327 / 328 | 97% | 4.23 | 172 / 178 |
thymus | 100% | 247.58 | 653 / 653 | 94% | 4.16 | 566 / 605 |
esophagus | 99% | 155.29 | 1430 / 1445 | 95% | 3.10 | 173 / 183 |
breast | 99% | 153.33 | 456 / 459 | 93% | 2.90 | 1037 / 1118 |
bladder | 100% | 183.43 | 21 / 21 | 91% | 3.29 | 457 / 504 |
intestine | 100% | 211.83 | 966 / 966 | 88% | 2.49 | 465 / 527 |
liver | 98% | 182.61 | 222 / 226 | 87% | 5.27 | 355 / 406 |
adrenal gland | 100% | 175.38 | 257 / 258 | 86% | 2.38 | 197 / 230 |
lung | 99% | 191.50 | 575 / 578 | 85% | 3.05 | 983 / 1155 |
kidney | 100% | 211.03 | 89 / 89 | 81% | 4.00 | 732 / 901 |
stomach | 99% | 139.78 | 356 / 359 | 81% | 2.28 | 233 / 286 |
prostate | 100% | 271.02 | 245 / 245 | 80% | 1.94 | 403 / 502 |
ovary | 99% | 140.34 | 178 / 180 | 79% | 4.78 | 340 / 430 |
skin | 98% | 121.11 | 1766 / 1809 | 78% | 2.39 | 366 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.28 | 29 / 29 |
spleen | 100% | 426.34 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.54 | 1 / 1 |
adipose | 100% | 149.83 | 1198 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 113.38 | 1292 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 100.05 | 829 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 3.61 | 39 / 45 |
peripheral blood | 69% | 56.07 | 639 / 929 | 0% | 0 | 0 / 0 |
muscle | 65% | 36.82 | 518 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 1.48 | 36 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007601 | Biological process | visual perception |
GO_0002009 | Biological process | morphogenesis of an epithelium |
GO_0005515 | Molecular function | protein binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
Gene name | CRYGS |
Protein name | Gamma-crystallin S (Beta-crystallin S) (Gamma-S-crystallin) |
Synonyms | hCG_16149 CRYG8 DKFZp434A0627 |
Description | FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . |
Accessions | P22914 ENST00000392499.6 Q9UFA7 A0A140CTX8 ENST00000307944.6 A0A1B1PFW0 |